In this podcast series sponsored by Biopharmaceutical Section of American Statistical Association, key opinion leaders from pharmaceutical industry and regulatory agencies talk about upcoming statistical conferences and events, and discuss current issues in Biopharmaceutical statistics.
http://community.amstat.org/BioP/Home/
Gesamtlänge aller Episoden: 3 days 2 hours 4 minutes
Episode 28: The Caucus for Women in Statistics
Nancy Flournoy, Ji-Hyun Lee, Paula Roberson and Jiayang Sun discuss the goals and activities of the caucus.
Episode 26: Data Transparency
Michael Hale, Jonathan Hartzel, Sara Hughes, Ted Lystig & Estelle Russek-Cohen discuss the implications of data transparency for the pharmaceutical industry.
Episode 25: Interview with Greg Campbell
Greg Campbell discusses his career at the FDA and shares his thoughts on the future of medical product development.
Episode 24: International Society for Biopharmaceutical Statistics
Amit Bhattacharyya, Jie Chen, Frank Fan & Yang Song discuss the mission of the ISBS and the regulatory environment in China.
Episode 23: Wei Zhang and Richard Zink
Wei and Richard discuss the 2015 ASA Biopharmaceutical Section Statistics Workshop. Rima Izem conducts the interview.
Episode 22: Qi Jiang and Olga Marchenko
Qi and Olga discuss the first scientific working group of the ASA Biopharmaceutical Section.
Episode 21: Interview with Dionne Price
As current Chair for the Biopharmaceutical Section, Dionne discusses her goals for the upcoming year.
Episode 20: Interview with Chrissie Fletcher
Chrissie Fletcher discusses EFSPI, the European Federation of Statisticians in the Pharmaceutical Industry.
Episode 19: Interview with Zoran Antonijevic
Zoran Antonijevic discusses the DIA Scientific Working Group on Adaptive Designs, and the upcoming Joint Adaptive Design and Bayesian Statistics Conference in Feb 2015.